Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

SAVASAVA
8 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in FILANA THERAPEUTICS INC

STIFEL FINANCIAL CORP holds 75,000 shares of SAVA (FILANA THERAPEUTICS INC), worth $89,250 as of 2026-Q2. This is a new position. SAVA represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$89,250

Current Shares

75,000

Total Value Change

-$2.4M

Total Shares Change

+20,122

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
75,000
-
$89,2500.0%$2.22
30
2022-Q3
Exited
0
-100.0%
$00.0%$43.07
0
2022-Q2
Decreased
87,175
-3.2%
$2.5M0.0%$29.75
0
2022-Q1
Increased
90,047
+1.6%
$3.3M0.0%$38.54
27
2021-Q4
Increased
88,645
+62.1%
$3.9M0.0%$43.77
39
2021-Q3
Decreased
54,667
-7.6%
$3.4M0.0%$62.14
0
2021-Q2
Increased
59,178
+7.8%
$5.1M0.0%$82.97
29
2021-Q1
New
54,878
-
$2.5M0.0%$43.96
36

Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used